R-CHOP regimen
WikiDoc Resources for R-CHOP regimen |
Articles |
---|
Most recent articles on R-CHOP regimen Most cited articles on R-CHOP regimen |
Media |
Powerpoint slides on R-CHOP regimen |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on R-CHOP regimen at Clinical Trials.gov Trial results on R-CHOP regimen Clinical Trials on R-CHOP regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on R-CHOP regimen NICE Guidance on R-CHOP regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on R-CHOP regimen Discussion groups on R-CHOP regimen Patient Handouts on R-CHOP regimen Directions to Hospitals Treating R-CHOP regimen Risk calculators and risk factors for R-CHOP regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for R-CHOP regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords: Rituximab-Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Prednisone regimen
Overview
R-CHOP regimen refers to an immunochemotherapy regimen consisting of rituximab, cyclophosphamide, hydroxydaunorubicin hydrochloride (doxorubicin hydrochloride), vincristine (Oncovin) and prednisone used to treat both indolent and aggressive forms of non-Hodgkin lymphoma.[1][2]
Regimen
H – Doxorubicin (Hydroxydaunomycin)
Indications
See also
- CEP regimen
- CHOEP regimen
- CHOP regimen
- COP regimen
- R-CHOEP regimen
- R-Maxi-CHOP regimen
- R-Mega-CHOEP regimen
References
- ↑ "NCI Thesaurus".
- ↑ "R-CHOP - National Cancer Institute".
- ↑ Coiffier, Bertrand (2002-01-24). "CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma". The New England Journal of Medicine. 346 (4): 235–242. doi:10.1056/NEJMoa011795. ISSN 1533-4406. PMID 11807147. Unknown parameter
|coauthors=
ignored (help)